Clinical Trial Update: Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating hepatic arterial infusion with intravenous irinotecan, 5-fluorouracil and leucovorin, with or without panitumumab, in patients with w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• Panitumumab (panitumumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-10-09